Mizuno R - Search Results

1

Real-world outcomes of avelumab plus axitinib in patients with advanced renal cell carcinoma in Japan: long-term follow-up from the J-DART2 retrospective study.

Kato T, Furukawa J, Hinata N, Ueda K, Hara I, Hongo F, Mizuno R, Okamoto T, Okuno H, Ito T, Kajita M, Oya M, Tomita Y, Shinohara N, Eto M, Uemura H. Kato T, et al. Among authors: mizuno r. Int J Clin Oncol. 2025 Jan;30(1):99-109. doi: 10.1007/s10147-024-02618-9. Epub 2024 Nov 16. Int J Clin Oncol. 2025. PMID: 39549218 Free PMC article.

2

Increased activation of CCAAT/enhancer binding protein-beta correlates with the invasiveness of renal cell carcinoma.

Oya M, Horiguchi A, Mizuno R, Marumo K, Murai M. Oya M, et al. Among authors: mizuno r. Clin Cancer Res. 2003 Mar;9(3):1021-7. Clin Cancer Res. 2003. PMID: 12631601

3

Increased nuclear factor-kappa B activation is related to the tumor development of renal cell carcinoma.

Oya M, Takayanagi A, Horiguchi A, Mizuno R, Ohtsubo M, Marumo K, Shimizu N, Murai M. Oya M, et al. Among authors: mizuno r. Carcinogenesis. 2003 Mar;24(3):377-84. doi: 10.1093/carcin/24.3.377. Carcinogenesis. 2003. PMID: 12663495

4

Differential expression of activator protein-2 isoforms in renal cell carcinoma.

Oya M, Mikami S, Mizuno R, Miyajima A, Horiguchi Y, Nakashima J, Marumo K, Mukai M, Murai M. Oya M, et al. Among authors: mizuno r. Urology. 2004 Jul;64(1):162-7. doi: 10.1016/j.urology.2004.02.022. Urology. 2004. PMID: 15245963

5

Inhibition of MKP-1 expression potentiates JNK related apoptosis in renal cancer cells.

Mizuno R, Oya M, Shiomi T, Marumo K, Okada Y, Murai M. Mizuno R, et al. J Urol. 2004 Aug;172(2):723-7. doi: 10.1097/01.ju.0000124990.37563.00. J Urol. 2004. PMID: 15247770

6

Inhibition of the ubiquitin-proteasome pathway activates stress kinases and induces apoptosis in renal cancer cells.

Ishizawa J, Yoshida S, Oya M, Mizuno R, Shinojima T, Marumo K, Murai M. Ishizawa J, et al. Among authors: mizuno r. Int J Oncol. 2004 Sep;25(3):697-702. Int J Oncol. 2004. PMID: 15289872

7

Akt activation in renal cell carcinoma: contribution of a decreased PTEN expression and the induction of apoptosis by an Akt inhibitor.

Hara S, Oya M, Mizuno R, Horiguchi A, Marumo K, Murai M. Hara S, et al. Among authors: mizuno r. Ann Oncol. 2005 Jun;16(6):928-33. doi: 10.1093/annonc/mdi182. Epub 2005 Apr 25. Ann Oncol. 2005. PMID: 15851405 Free article.

8

C-jun activation in acquired cystic kidney disease and renal cell carcinoma.

Oya M, Mikami S, Mizuno R, Marumo K, Mukai M, Murai M. Oya M, et al. Among authors: mizuno r. J Urol. 2005 Aug;174(2):726. doi: 10.1097/01.ju.0000164656.99251.77. J Urol. 2005. PMID: 16006965

9

Repeated regression of pulmonary metastases from renal cell carcinoma after treatment using different interferon-alpha preparations.

Oya M, Asakura H, Mizuno R, Marumo K, Murai M. Oya M, et al. Among authors: mizuno r. Biomed Res. 2005 Jun;26(3):135-7. doi: 10.2220/biomedres.26.135. Biomed Res. 2005. PMID: 16011307 Free article.

10

Modulation of bcl-2 family proteins in MAPK independent apoptosis induced by a cdc25 phosphatase inhibitor Cpd 5 in renal cancer cells.

Mizuno R, Oya M, Hara S, Matsumoto M, Horiguchi A, Ohigashi T, Marumo K, Murai M. Mizuno R, et al. Oncol Rep. 2005 Sep;14(3):639-44. Oncol Rep. 2005. PMID: 16077967

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

474 results

Search Page

Filters